M1 Kliniken: Beauty growth lifts margins as trading exit completes
M1 Kliniken says its Beauty segment delivered double-digit revenue and EBIT growth, while the trading segment was exited after selling HAEMATO Pharm GmbH. Group EBIT margin improved significantly; targets EUR 200–300 million Beauty revenue by 2029.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.